The DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies
Abstract
Introduction: Numerous studies have demonstrated that abnormal levels of cholesterol are associated with a high attributable risk for the occurrence of cardiovascular disease (CVD). However, there has been no comprehensive study to investigate the relationship between serum cholesterol levels and cardiovascular mortality. Therefore, we conducted a systematic review and dose-response meta-analysis. Methods: A systematic literature search of key databases, including EMBASE and MEDLINE, was conducted and included all the published epidemiological studies that contained estimates of the hazard ratios (HR) of serum cholesterol of CVD mortality. Data extraction, eligibility, and assessment of the risk of bias were assessed by two reviewers independently. All published risk estimates were hazard ratios and analyzed by quantitative meta-analysis using a random-effects model and dose-response relationships of serum cholesterol with CVD mortality. Results: A total of 14 independent reports, including 1,055,309 subjects and 9457 events, were analyzed. The pooled HR (95% CI) was 1.27 (95% CI, 1.19–1.36) for total cholesterol, 1.21 (95% CI, 1.09–1.35) for low-density lipoprotein cholesterol (LDL-C), and 0.60 (95% CI, 0.50–0.72) for high-density lipoprotein cholesterol (HDL-C). We observed a linear association between serum cholesterol (TC, HDL-C) levels and CVD mortality in this meta-analysis. Conclusions: Serum total cholesterol and LDL-C level is associated with increased CVD mortality, but HDL-C level is inversely associated with CVD mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Higgins, J. P. T., Altman, D. G., Gotzsche, P. C., Juni, P., Moher, D., Oxman, A. D., Savovic, J., Schulz, K. F., Weeks, L., Sterne, J. A. C., et al. (2011) · BMJ · doi:10.1136/bmj.d5928 · Cited by 33,817
Stang, A. (2010) · European Journal of Epidemiology · doi:10.1007/s10654-010-9491-z · Cited by 17,396
Yusuf, S., Hawken, S., Ôunpuu, S., Dans, T., Avezum, A., Lanas, F., McQueen, M., Budaj, A., Pais, P., Varigos, J., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17018-9 · Cited by 12,026
Prediction of coronary heart disease using risk factor categories
Wilson, P. W. F., D’Agostino, R. B., Levy, D., Belanger, A. M., Silbershatz, H., & Kannel, W. B. (1998) · Circulation · doi:10.1161/01.cir.97.18.1837 · Cited by 9,581
Interpretation of random effects meta-analyses
Riley, R. D., Higgins, J. P. T., & Deeks, J. J. (2011) · BMJ · doi:10.1136/bmj.d549 · Cited by 2,884 · cited 1×
“However, we noted that overall statistical heterogeneity for each meta-analysis, as measured by the I2 statistic, was moderate, and we chose a random-effect model to account for differences in effect size between each study [53].”
MethodMethods for Trend Estimation from Summarized Dose-Response Data, with Applications to Meta-Analysis
Greenland, S., & Longnecker, M. P. (1992) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a116237 · Cited by 2,353
Stewart, L. A., Clarke, M., Rovers, M., Riley, R. D., Simmonds, M., Stewart, G., & Tierney, J. F. (2015) · JAMA · doi:10.1001/jama.2015.3656 · Cited by 2,134
Statins for the primary prevention of cardiovascular disease
Taylor, F., Huffman, M. D., Macedo, A. F., Moore, T. H., Burke, M., Davey Smith, G., Ward, K., Ebrahim, S., & Gay, H. C. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004816.pub5 · Cited by 1,934
Research works printed but not linked: 34
- Fuster, V., and Kelly, B.B. (2010). The National Academies Collection: Reports funded by National Institutes of Health. Promoting Cardiovascular Health in the Developing World: A Critical Challenge to Achieve Global Health, National Academies Press (US).
- Casula, M., Colpani, O., Xie, S., Alberico, L., and Baragetti, A. (2021). HDL in Atherosclerotic Cardiovascular Disease: In Search of a Role. Cells, 10. · DOI
- Stamler, 2000, Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular, and all-cause mortality and to longevity, JAMA, 284, 311, 10.1001/jama.284.3.311 · DOI · Paper page
- Gofman, 1954, Lipoproteins, coronary heart disease, and atherosclerosis, Physiol. Rev., 34, 589, 10.1152/physrev.1954.34.3.589 · DOI · Paper page
- Steinberg, 2009, The LDL modification hypothesis of atherogenesis: An update, J. Lipid Res., 50, S376, 10.1194/jlr.R800087-JLR200 · DOI · Paper page
- Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am. J. Med., 62, 707, 10.1016/0002-9343(77)90874-9 · DOI · Paper page
- Knobloch, 2011, Preferred reporting items for systematic reviews and meta-analyses (PRISMA) statement and publication bias, J. Craniomaxillofacial Surg., 39, 91, 10.1016/j.jcms.2010.11.001 · DOI · Paper page
- Sackett, 1979, Bias in analytic research, J. Chronic Dis., 32, 51, 10.1016/0021-9681(79)90012-2 · DOI · Paper page
- Orsini, 2006, Generalized least squares for trend estimation of summarized dose-response data, Stata J., 6, 40, 10.1177/1536867X0600600103 · DOI · Paper page
- Higgins, 2002, Quantifying heterogeneity in a meta-analysis, Stat. Med., 21, 1539, 10.1002/sim.1186 · DOI · Paper page
- Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
- DerSimonian, 1986, Meta-analysis in clinical trials, Control Clin. Trials, 7, 177, 10.1016/0197-2456(86)90046-2 · DOI · Paper page
- Hirata, 2016, The Relationship between Very High Levels of Serum High-Density Lipoprotein Cholesterol and Cause-Specific Mortality in a 20-Year Follow-Up Study of Japanese General Population, J. Atheroscler. Thromb., 23, 800, 10.5551/jat.33449 · DOI
- Hirata, 2018, Association of extremely high levels of high-density lipoprotein cholesterol with cardiovascular mortality in a pooled analysis of 9 cohort studies including 43,407 individuals: The EPOCH-JAPAN study, J. Clin. Lipidol., 12, 674, 10.1016/j.jacl.2018.01.014 · DOI
- Okamura, 2006, The inverse relationship between serum high-density lipoprotein cholesterol level and all-cause mortality in a 9.6-year follow-up study in the Japanese general population, Atherosclerosis, 184, 143, 10.1016/j.atherosclerosis.2005.03.042 · DOI
- Kilander, 2001, Education, lifestyle factors and mortality from cardiovascular disease and cancer. A 25-year follow-up of Swedish 50-year-old men, Int. J. Epidemiol., 30, 1119, 10.1093/ije/30.5.1119 · DOI · Paper page
- Johan, 2006, Clinical value of the metabolic syndrome for long term prediction of total and cardiovascular mortality: Prospective, population based cohort study, BMJ, 332, 878, 10.1136/bmj.38766.624097.1F · DOI · Paper page
- Kunutsor, 2017, Is High Serum LDL/HDL Cholesterol Ratio an Emerging Risk Factor for Sudden Cardiac Death? Findings from the KIHD Study, J. Atheroscler. Thromb., 24, 600, 10.5551/jat.37184 · DOI · Paper page
- Oksala, 2013, Complementary prediction of cardiovascular events by estimated apo- and lipoprotein concentrations in the working age population. The Health 2000 Study, Ann. Med., 45, 141, 10.3109/07853890.2012.679962 · DOI
- Holme, 2011, Association of coronary heart disease mortality with risk factors according to length of follow-up and serum cholesterol level in men: The Oslo Study cohort, Eur. J. Prev. Cardiol., 20, 168, 10.1177/1741826711432514 · DOI
- Tikhonoff, 2005, Low-density lipoprotein cholesterol and mortality in older people, J. Am. Geriatr. Soc., 53, 2159, 10.1111/j.1532-5415.2005.00492.x · DOI
- Hu, 2017, A novel cardiovascular death prediction model for Chinese individuals: A prospective cohort study of 381,963 study participants, Atherosclerosis, 264, 19, 10.1016/j.atherosclerosis.2017.07.016 · DOI
- Thorgeirsson, 2005, Risk factors for out-of-hospital cardiac arrest: The Reykjavik Study, Eur. Heart J., 26, 1499, 10.1093/eurheartj/ehi179 · DOI
- Ravnskov, 2003, High cholesterol may protect against infections and atherosclerosis, QJM, 96, 927, 10.1093/qjmed/hcg150 · DOI
- Ulmer, 2004, Why Eve is not Adam: Prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality, J. Women’s Health, 13, 41, 10.1089/154099904322836447 · DOI
- Ravnskov, 2002, Is atherosclerosis caused by high cholesterol?, QJM, 95, 397, 10.1093/qjmed/95.6.397 · DOI
- Ray, 2014, The ACC/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: The good the bad and the uncertain: A comparison with ESC/EAS guidelines for the management of dyslipidaemias 2011, Eur. Heart J., 35, 960, 10.1093/eurheartj/ehu107 · DOI · Paper page
- Pignone, 2000, Use of lipid lowering drugs for primary prevention of coronary heart disease: Meta-analysis of randomised trials, BMJ, 321, 983, 10.1136/bmj.321.7267.983 · DOI · Paper page
- Kannel, 1964, Risk factors in coronary heart disease: An evaluation of several serum lipids as predictors of coronary heart disease: The framingham study, Ann. Intern. Med., 61, 888, 10.7326/0003-4819-61-5-888 · DOI · Paper page
- Gao, 2012, Lipid-related markers and cardiovascular disease prediction, JAMA, 307, 2499
- Lu, 2013, Low HDL-C predicts risk and PCI outcomes in the Han Chinese population, Atherosclerosis, 226, 193, 10.1016/j.atherosclerosis.2012.09.011 · DOI
- Rubin, 1991, Inhibition of early atherogenesis in transgenic mice by human apolipoprotein AI, Nature, 353, 265, 10.1038/353265a0 · DOI · Paper page
- Tangirala, 1999, Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice, Circulation, 100, 1816, 10.1161/01.CIR.100.17.1816 · DOI · Paper page
- Egger, 1997, Bias in meta-analysis detected by a simple, graphical test, BMJ, 315, 629, 10.1136/bmj.315.7109.629 · DOI · Paper page
Metadata
- Authors
- Jung, E., Kong, S. Y., Ro, Y. S., Ryu, H. H., & Shin, S. D.
- Venue
- International Journal of Environmental Research and Public Health
- Publisher
- MDPI AG
- Published
- 2022-07-06
- Volume
- 19
- Issue
- 14
- Pages
- 8272
- ISSN
- 1660-4601
- Cited by
- 211
- References
- 19
- Language
- en
- Funders
- Chonnam National University Hospital (BCRI-19018)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. https://app.cochat.ai/papers/10.3390/ijerph19148272
- The paper
- Jung, E., Kong, S. Y., Ro, Y. S., Ryu, H. H., & Shin, S. D. (2022). Serum Cholesterol Levels and Risk of Cardiovascular Death: A Systematic Review and a Dose-Response Meta-Analysis of Prospective Cohort Studies. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph19148272
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.